Viewing Study NCT00410358


Ignite Creation Date: 2025-12-25 @ 12:21 AM
Ignite Modification Date: 2026-01-22 @ 3:18 PM
Study NCT ID: NCT00410358
Status: COMPLETED
Last Update Posted: 2020-12-19
First Post: 2006-12-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Dose Escalation of Gimatecan Administered Orally to Japanese Patients With Advanced Solid Tumor.
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Gimatecan View
None topoisomerase I inhibitor View
None advanced solid tumors View